OKLAHOMA CITY, July 28, 2015 /PRNewswire/ -- PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (OTC: PDRX) today announced that it has partnered with Dobson Technologies, a fully-integrated outsourced IT provider, for their Infrastructure as a Service (IaaS) product.
PD-Rx is an Application Service Provider (ASP) to medical practices across the United States. Using Dobson Technologies' IaaS solution will allow PD-Rx to improve disaster recovery and business continuity, ensure regulatory compliance, and reduce operating expenses. "The most important aspect of our business is our customers, and this partnership allows us to provide the best service possible to those customers," states Jack McCall, Executive Vice President & COO. "Not only does this provide direct benefits, such as reducing downtime and providing maximum security of data, but it also gives us the flexibility to adapt and grow with our increasing customer base."
Dobson Technologies has been a trusted and dependable communication and technology services provider for more than 75 years. Their geographically-separate data centers and fiber optic network deliver cloud-based data protection, virtualization and disaster recovery services with regulatory-compliant, industry-leading technology.
ABOUT THE COMPANY:
PD-Rx offers pharmaceutical and management strategies to the healthcare industry. Our management strategies focus on new products, solid business partners, and the specialized segment of the pharmaceutical industry. As a licensed FDA manufacturer and packager, PD-Rx offers a full spectrum of medications and specialized services. Our goal is to develop a matrix of cost containment tools and products that we can merge into any healthcare network to enhance patient care and improve managed care organizations bottom line. We provide proprietary products and prepackaged medications that are viewed by patient, insurance payers and healthcare providers as a progressive and responsive practice.
This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks and uncertainties or other factors, which may cause actual results, performance or achievements expressed or implied by such forward-looking statements to vary from those forecast or implied in this release. Factors that might cause such a difference include, without limitation, decline in demand for the company's products or services, and the effect of general economic conditions and factors affecting the industry.
For Further Information, Contact:
Jack L. McCall, EVP & COO
Ph. 405-942-3040 / firstname.lastname@example.org
SOURCE PD-Rx Pharmaceuticals, Inc.